share_log

嘉必优生物技术(武汉)股份有限公司董事会关于本次交易预计构成重大资产重组但不构成重组上市的说明

Explanation of the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. that the transaction is expected to constitute a major asset restructuring but not a restructuring listing

SZSI ·  Nov 12, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more